Elanco Animal Health | Elanco Ventures

corporate vc$25MCo-investsLeads rounds

◆ Fund Size

$25M

◆ Check Size

$0.5M→$25.0M

◆ Location

United States

◆ Portfolio

5 companies

◆ Activity

Statusraising

◆ Links

Website ↗@Elanco on X ↗

◆ Investment Thesis

Support and advance innovation in animal health through strategic investments in therapeutic advancements and supportive technologies.

◆ About Elanco Animal Health

Elanco Ventures is Elanco Animal Health’s corporate venture capital platform focused on early-stage animal health innovation, with an announced $25 million multi-year commitment and a planned launch in late 2026.[1] It targets Pre-Seed, Seed, and Series A companies working on therapeutic advancements and enabling technologies for animal care.[1]

◆ Sectors

Drug DiscoveryBiotechDiagnosticsMedtechHealthtech Infrastructure

◆ Stages

pre-seedseedseries-a

◆ Geography Focus

United States

◆ Team

Name	Title	Role	Links
Tim Bettington	Executive Vice President, Center of Strategic Growth	Executive	in
Eric Steager	Manager	partner
Jeff Simmons	President and CEO	C-Level	in
Tiffany Kanaga	Investor Contact	staff	in

◆ Notable Investments

AgTech AcceleratorGalliprantCredelioTrifexisMaxibanDenagard

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Elanco Ventures invest in?

Elanco Ventures invests in Drug Discovery, Biotech, Diagnostics, Medtech and Healthtech Infrastructure at the pre-seed, seed and series-a stages.

Which geographies does Elanco Ventures focus on?

Elanco Ventures focuses on United States, and is headquartered in United States.

What is Elanco Ventures's typical check size?

Elanco Ventures typically writes checks of $0.5M to $25M.